GW Pharmaceuticals PLC (GWPH)

128.43 +0.82  +0.64% NASDAQ Nov 27, 09:38 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/25/2021 Earnings GW Pharmaceuticals PLC Fourth Quarter Earnings for 2020 Release
02/25/2021 16:30 EST Misc GW Pharmaceuticals PLC Fourth Quarter Earnings Conference Call for 2020
11/03/2020 Earnings GW Pharmaceuticals PLC Third Quarter Earnings Result for 2020
11/03/2020 08:30 EST Misc GW Pharmaceuticals PLC Third Quarter Earnings Conference Call for 2020
08/06/2020 16:30 EDT Misc GW Pharmaceuticals PLC Second Quarter Earnings Conference Call for 2020
08/06/2020 Earnings GW Pharmaceuticals PLC Second Quarter Earnings Result for 2020
05/26/2020 11:00 EDT Misc GW Pharmaceuticals PLC Annual General Meeting for 2019
05/11/2020 16:30 EDT Misc GW Pharmaceuticals PLC First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings GW Pharmaceuticals PLC First Quarter Earnings Result for 2020
02/27/2020 Misc GW Pharmaceuticals PLC Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.gwpharm.com
  • Investor Relations URL: http://ir.gwpharm.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Feb. 25, 2021
  • Last Earnings Release: Nov. 03, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Top Fund Holders

Symbol Name Weighting
HMMJ.TO Horizons Marijuana Life Sciences ETF 11.40%
TOKE Cambria Cannabis ETF 9.54%
MJ ETFMG Alternative Harvest ETF 8.49%
POTX Global X Cannabis ETF 8.09%
YOLO AdvisorShares Pure Cannabis ETF 6.88%
FRBRX Franklin Biotechnology Discovery R6 2.94%
RSMMX Victory RS Small Cap Equity Member 2.62%
NPP5423 Ninepoint UIT Alternative Health I 2.53%
BCSVX Brown Capital Mgmt Intl Sm Co Inv 2.27%
PFC4201 Purpose Marijuana Opportunities Cl F 1.92%
ETCHX Eventide Healthcare & Life Sciences C 1.73%
PPH VanEck Vectors Pharmaceutical ETF 1.25%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.